News
Zacks.com on MSN11d
VRTX Secures Nod for Expanded Use of CF Drug Kaftrio in EuropeWith the latest approval, Vertex's Kaftrio is now eligible to treat about 4,000 people living in the EU with rare mutations ...
"We are pleased that the European Commission has broadened the KAFTRIO indication to include all CF patients 2 years and older who have at least one non-class I mutation, ensuring that even more ...
US biotech company Vertex Pharmaceuticals (Nasdaq: VRTX) has received European Commission approval to extend the use of its ...
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in a combination ...
Vertex Pharmaceuticals (VRTX) announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO in a ...
(RTTNews) - Vertex Pharmaceuticals (VRTX) announced that the European Commission has approved a label expansion for KAFTRIO (ivacaftor/tezacaftor/elexacaftor) in ...
Glasgow Times on MSN8d
Cystic fibrosis patient to debut comedy show after brush with deathHowever in 2020, she received a life-changing cystic fibrosis drug called Kaftrio, which transformed her life and drastically ...
The Independent on MSN8d
Cystic fibrosis patient turns brush with death into Edinburgh Fringe showYvonne Hughes, 51, from Clydebank in West Dunbartonshire, has lived with cystic fibrosis (CF) – a condition which causes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback